Chile, Belarus Poised to Join the Growing List of Global South Countries That Will Produce Chinese COVID-19 Vaccines

Source: Bridge Consulting

China’s drive to build manufacturing capacity for its COVID vaccines in countries across the Global South is poised to expand. Talks are now underway to build so-called “fill and finish” facilities in both Belarus and Chile.

Chinese pharmaceutical companies already have 14 production agreements in place, predominantly in Asia, Africa, and the Americas, according to data from Bridge Consulting in Beijing.

So far, only one plant in Brazil is producing significant quantities. The rest are expected to steadily ramp up output in the months ahead.

Currently, Chinese manufacturing capacity in Africa is restricted to North African countries including Egypt, Morocco, and Algeria.

SUGGESTED READING:

by Eric Olander

Most Read

1 Developing Countries’ Debt Servicing Costs to China Are Significant, but Nowhere Near as Much as Other Creditors
2 Chinese Military Fans Discuss Why Indonesia Bought Rafale Instead of J-10C
3 Chinese Cargo Planes Secretly Ferrying Supplies to Iran, Claim Online Sleuths
4 From J-10C to Kaan? Indonesia’s Fighter Jet Deal With Turkey Shocks Chinese Military Fans
5 Indonesia Goes Nuclear, Taps China and Russia for Modular Reactors
6 Thailand in Last-Minute U.S. Talks as 36% Tariff Looms

What is The China-Global South Project?

Independent

The China-Global South Project is passionately independent, non-partisan and does not advocate for any country, company or culture.

News

A carefully curated selection of the day’s most important China-Global South stories. Updated 24 hours a day by human editors. No bots, no algorithms.

Analysis

Diverse, often unconventional insights from scholars, analysts, journalists and a variety of stakeholders in the China-Global South discourse.

Networking

A unique professional network of China-Africa scholars, analysts, journalists and other practioners from around the world.

More about CGSP